World Intellectual Property Organization issues patent to Datwyler Pharma Packaging for invention relating to closure cap for container receiving pharmaceuticals
October 30, 2012
(U.S. Fed News)
– Publication No. WO/2012/143338 was published on Oct. 26.
Title of the invention: "CLOSURE CAP."
Applicants: DATWYLER PHARMA PACKAGING BELGIUM NV (BE), WAEBEN Reinhard Louis Jozef (BE), DITTMER Ralf (DE) and VRIJENS Ronny Prosper Elisabeth (BE).
Inventors: Reinhard Louis Jozef Waeben (BE), Ronny Prosper Elisabeth Vrijens (BE) and Ralf Dittmer (DE).
According to the abstract posted by the World Intellectual Property Organization: "The invention relates to a closure cap (1) for a container (2) for receiving a pharmaceutical substance, in particular for an infusion or transfusion bottle, with a flanged cap (4) which is suitable for engagement around a container neck (8) and which has a metal film layer, wherein the flanged cap (4) also has a recess (5) that is covered by a plastic lid (3), the plastic lid (3) is connected to the flanged cap (4) by means of at least one connection element (9) formed on the underside, and the plastic lid (3) is removable at least in part. In order to provide a closure cap for a container for receiving a pharmaceutical substance, which container is safe to handle and meets strict demands regarding its tamper-proofing, it is proposed that the plastic lid (3) is connected to the flanged cap (4) via a plurality of connection elements (9) which are formed on its underside and pass through associated connection openings (11) formed in the flanged cap (4), and that the plastic lid (3), in order to expose the recess (5), has a tear-off tab (12) which extends from a coverage of the recess (5) as far as an edge of the plastic lid (3), wherein no connection between the plastic lid and the flanged cap (4) is formed in the area of the tear-off tab (12)."
The patent was filed on April 17 under Application No. PCT/EP2012/056961.
For further information please visit: http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2012143338
For any query with respect to this article or any other content requirement, please contact Editor at email@example.com
(c) 2012 US Fed News (HT Syndication)